Clinical Trials List
Protocol NumberhGZP-101
Active
2021-01-01 - 2026-06-30
Phase I
Recruiting1
ICD-10C43.0
Malignant melanoma of lip
ICD-10D03.0
Melanoma in situ of lip
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9172.0
Malignant melanoma of skin of lip
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 枋岳甫 Division of Thoracic Medicine
- Wen-Cheng Chang Division of Hematology & Oncology
- Kung-Chu Ho Division of Nuclear Medicine
- Cheng-Ta Yang Division of Thoracic Medicine
- 吳教恩 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
25 participants
